Related Experiment Video
Updated: May 3, 2026
07:01
Navigating the Mass Spectrometry-Based Proteomic Data Using Free Computational Tools
Published on: August 19, 2025
1.2K
Serum proteomics for gastric cancer
Wentao Liu1, Qiumeng Yang1, Bingya Liu1
1Key Laboratory of Shanghai Gastric Neoplasms, Department of Surgery, Ruijin Hospital, Shanghai Jiao Tong University, Shanghai Institute of Digestive Surgery, Shanghai 200025, PR China.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|February 15, 2014
Summary
Gastric cancer, a leading cause of death, requires early diagnosis. Proteomics techniques are vital for discovering new serum tumor biomarkers for earlier and more reliable gastric cancer detection.
Area of Science:
- Oncology
- Biochemistry
- Proteomics
Background:
- Gastric cancer is the second leading cause of cancer death globally, often diagnosed at advanced stages due to nonspecific early symptoms.
- Early diagnosis and treatment are critical for improving prognosis, but current serum tumor biomarkers lack sufficient sensitivity and specificity.
- Advanced proteomics techniques offer a promising avenue for identifying novel, reliable biomarkers for early gastric cancer detection.
Purpose of the Study:
- To review serum proteomics techniques for gastric cancer research.
- To highlight the importance of discovering new serum tumor biomarkers for early diagnosis.
- To discuss the application of proteomics in identifying novel biomarkers such as SAA, plasminogen, and C9c.
Main Methods:
- Differential analysis of serum proteins using proteomics techniques.
- Application of proteomic-based methods like Surface-Enhanced Laser Desorption/Ionization (SELDI) and High-Throughput Capillary Liquid Chromatography (HCLP).
- Serological proteomics strategies for biomarker discovery.
Main Results:
- Several novel serum tumor biomarkers, including Serum Amyloid A (SAA), plasminogen, and C9c, have been identified.
- Proteomics has enabled the discovery of potential biomarkers for gastric cancer.
- Existing biomarkers show limitations in specificity and sensitivity.
Conclusions:
- Serum proteomics techniques are essential for advancing gastric cancer research and early diagnosis.
- The discovery of new biomarkers through proteomics is crucial for overcoming the limitations of current diagnostic methods.
- Continued research using advanced proteomics is necessary for reliable early detection and improved patient outcomes.
